Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: May 3, 2013
Last updated: November 19, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2021
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)